Skip to main content
Yifeng Pharmacy Chain Co., Ltd. logo

Yifeng Pharmacy Chain Co., Ltd. — Investor Relations & Filings

Ticker · 603939 ISIN · CNE100001TS5 LEI · 300300CZZIF44N1EZO06 Shanghai Stock Exchange Wholesale and retail trade
Filings indexed 1,865 across all filing types
Latest filing 2020-11-30 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 603939

About Yifeng Pharmacy Chain Co., Ltd.

https://www.yfdyf.cn/

Yifeng Pharmacy Chain Co., Ltd. operates as a large-scale retail pharmacy enterprise. The company specializes in the distribution and sale of prescription drugs, over-the-counter medicines, traditional Chinese medicine, nutritional supplements, and medical devices. It utilizes a standardized management system across its extensive network of retail stores to ensure service quality and operational efficiency. Beyond physical retail, the company has developed a comprehensive digital healthcare ecosystem, integrating online-to-offline (O2O) services to provide professional pharmaceutical consultations and health management solutions. Its business model focuses on a "big health" strategy, aiming to provide accessible healthcare products and professional services to a broad consumer base through optimized supply chain logistics and a diversified product portfolio.

Recent filings

Filing Released Lang Actions
第三届监事会第二十六次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of a supervisory board meeting resolution by 益丰大药房连锁股份有限公司. It details the meeting date, attendance, voting results, and approval of a proposal regarding a bank credit facility and related party guarantee. The document is short (903 characters) and does not contain financial statements or detailed financial data. It is an announcement of a board/management decision rather than a full report or financial filing. Therefore, it fits best under Board/Management Information (MANG).
2020-11-30 Chinese
第三届董事会第二十七次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at a board meeting of 益丰大药房连锁股份有限公司 (Yifeng Pharmacy Chain Co., Ltd.). It details the convening of the third board's 27th meeting, attendance, voting results, and specific agenda items such as the appointment of a board secretary and approval of a bank credit facility with related party guarantees. The document includes voting outcomes and references to further announcements on the stock exchange website. There is no financial data, earnings information, or report publication mentioned. The content clearly relates to board decisions and management changes, fitting the category of Board/Management Information (MANG). The document length is short (1273 characters), but it is not merely an announcement of a report publication or certification. Therefore, the classification is MANG with high confidence.
2020-11-30 Chinese
关于“益丰转债”开始转股的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the start of the conversion period for a convertible bond issued by 益丰大药房连锁股份有限公司. It details the bond issuance, conversion price, conversion period, procedures for bondholders to convert bonds into shares, and terms for adjusting the conversion price. The document is a formal public notice about the convertible bond conversion process and related terms, not a financial report or earnings release. It does not contain financial statements or management discussion but rather regulatory and procedural information about the convertible bond. The document length is 3634 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this fits best under Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes such as convertible bond issuance and conversion.
2020-11-30 Chinese
关于聘任董事会秘书的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the appointment of a new board secretary (董事会秘书) for the company 益丰大药房连锁股份有限公司. It includes details about the appointment resolution, qualifications of the appointee, and compliance with relevant laws and stock exchange rules. There is no financial data, no report or presentation, and no mention of voting results or dividends. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management.
2020-11-30 Chinese
关于向银行申请综合授信额度并接受关联方提供担保的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by the company Yifeng Pharmacy Chain Co., Ltd. regarding its application for a comprehensive credit line from a bank and acceptance of guarantees from related parties. It details the board's approval of the credit application, the guarantee provided by the actual controller, and the independent directors' opinions on the related party transaction. The document is short (1006 characters) and focuses on financing activities and guarantees, without containing financial statements or detailed financial analysis. It is not a full financial report, earnings release, or management discussion. It is an update on financing and credit arrangements, fitting the Capital/Financing Update category.
2020-11-30 Chinese
独立董事关于第三届董事会第二十七次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion statement from independent directors regarding specific company matters: the appointment of a board secretary and approval of a related-party guarantee for a bank credit facility. It references compliance with securities law, company law, and stock exchange listing rules. The content is focused on governance and board-related decisions rather than financial results or audit findings. The document length is short (868 characters), and it does not contain financial statements or detailed financial data. It is not an announcement of a report publication but a formal opinion on board matters. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of changes or decisions related to the board or senior management.
2020-11-30 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.